Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 25;56(6):e00323-18.
doi: 10.1128/JCM.00323-18. Print 2018 Jun.

Development of a Real-Time Reverse Transcription-PCR Assay for Global Differentiation of Yellow Fever Virus Vaccine-Related Adverse Events from Natural Infections

Affiliations

Development of a Real-Time Reverse Transcription-PCR Assay for Global Differentiation of Yellow Fever Virus Vaccine-Related Adverse Events from Natural Infections

Holly R Hughes et al. J Clin Microbiol. .

Abstract

Yellow fever (YF) is a reemerging public health threat, with frequent outbreaks prompting large vaccination campaigns in regions of endemicity in Africa and South America. Specific detection of vaccine-related adverse events is resource-intensive, time-consuming, and difficult to achieve during an outbreak. To address this, we have developed a highly transferable rapid yellow fever virus (YFV) vaccine-specific real-time reverse transcription-PCR (RT-PCR) assay that distinguishes vaccine from wild-type lineages. The assay utilizes a specific hydrolysis probe that includes locked nucleic acids to enhance specific discrimination of the YFV17D vaccine strain genome. Promisingly, sensitivity and specificity analyses reveal this assay to be highly specific to vaccine strain(s) when tested on clinical samples and YFV cell culture isolates of global origin. Taken together, our data suggest the utility of this assay for use in laboratories of varied capacity for the identification and differentiation of vaccine-related adverse events from wild-type infections of both African and South American origin.

Keywords: 17D vaccine; diagnostic; locked nucleic acids; real-time RT-PCR; yellow fever virus.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Standardization and specificity of yellow fever 17D vaccine virus-specific locked nucleic acid hydrolysis probes. Real-time RT-PCR locked nucleic acid probes were designed to be specific to a single nucleotide polymorphism identified in the yellow fever virus (YFV) vaccine genome. The specificity of primer set 8 was optimized by testing RNA from YFV strains 17D (vaccine) and Asibi (parental strain) at an annealing temperature (Ta) of 60°C or 64°C. RFU, relative fluorescence unit.
FIG 2
FIG 2
Limit of detection analysis of yellow fever 17D vaccine virus-specific real-time RT-PCR assay. Probit regression analysis of the yellow fever 17D-specific assay was performed at an annealing temperature of 64°C using serial dilutions of in vitro transcribed RNA copies. Solid circles represent positive test results. Dotted lines represent the 95% confidence interval. Cq, quantification cycle.

Similar articles

Cited by

References

    1. Monath TP, Vasconcelos PF. 2015. Yellow fever. J Clin Virol 64:160–173. doi:10.1016/j.jcv.2014.08.030. - DOI - PubMed
    1. Soper FL. 1963. The elimination of urban yellow fever in the Americas through the eradication of Aedes aegypti. Am J Public Health Nations Health 53:7–16. - PMC - PubMed
    1. Frierson JG. 2010. The yellow fever vaccine: a history. Yale J Biol Med 83:77–85. - PMC - PubMed
    1. Theiler M, Smith HH. 1937. The use of yellow fever virus modified by in vitro cultivation for human immunization. J Exp Med 65:787–800. doi:10.1084/jem.65.6.787. - DOI - PMC - PubMed
    1. Theiler M, Smith HH. 1937. The effect of prolonged cultivation in vitro upon the pathogenicity of yellow fever virus. J Exp Med 65:767–786. doi:10.1084/jem.65.6.767. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources